HFA
EDIT icon

Hoover Financial Advisors’s Editas Medicine EDIT Stock Holding History

Hoover Financial Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$27K Hold
472
– – ﹤0.01% 355
2021
Q1 		$15K Hold
472
– – ﹤0.01% 385
2020
Q4 		$36K Buy
+472
New +$19.4K 0.01% 265
2020
Q3 		– Sell
-472
Closed -$14K – 277
2020
Q2 		$14K Buy
+472
New +$12.3K 0.01% 310

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Hoover Financial Advisors's EDIT Position: Q2 2021 in Review

Hoover Financial Advisors held its Editas Medicine (EDIT) position steady in Q2 2021 at 472 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #355.

Hoover Financial Advisors first reported a position in EDIT in Q2 2020 and has held it in 4 quarters since. The position peaked at $36K in Q4 2020. 313 funds tracked by Wall St. Rank hold EDIT as of Q2 2021.

  • Hoover Financial Advisors held 472 shares of Editas Medicine worth $27K as of Q2 2021.
  • Hoover Financial Advisors left its Editas Medicine share count unchanged in Q2 2021.
  • Editas Medicine made up ﹤0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #355 holding.
  • Hoover Financial Advisors first reported a position in Editas Medicine in Q2 2020 and has held it in 4 quarters since.
  • Hoover Financial Advisors's Editas Medicine position peaked at $36K in Q4 2020.
  • 313 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.